Cargando…

SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: Recommendations from the French society for ImmunoTherapy of Cancer (FITC)

Detalles Bibliográficos
Autores principales:	Gauci, Marie-Léa, Coutzac, Clélia, Houot, Roch, Marabelle, Aurélien, Lebbé, Céleste
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891073/ https://www.ncbi.nlm.nih.gov/pubmed/33743480 http://dx.doi.org/10.1016/j.ejca.2021.02.003

Ejemplares similares

Introducing the society for immunotherapy of cancer’s new journal: journal for immunoTherapy of cancer
por: Romero, Pedro J, et al.
Publicado: (2013)

Local and distant response to intratumoral immunotherapy assessed by immunoPET in mice
por: Meyblum, Louis, et al.
Publicado: (2023)

Necroptosis in Immuno-Oncology and Cancer Immunotherapy
por: Sprooten, Jenny, et al.
Publicado: (2020)

Moving cancer immunotherapy forward through the Journal for ImmunoTherapy of Cancer (JITC)
por: Romero, Pedro
Publicado: (2019)

Intratumoural administration and tumour tissue targeting of cancer immunotherapies
por: Melero, Ignacio, et al.
Publicado: (2021)

The application of mechanobiotechnology for immuno-engineering and cancer immunotherapy
por: Yoon, Chi Woo, et al.
Publicado: (2022)

Trial Reporting in Immuno-Oncology (TRIO): an American society of clinical oncology-society for immunotherapy of cancer statement
por: Tsimberidou, Apostolia M., et al.
Publicado: (2018)

CAR-T cells and BiTEs in solid tumors: challenges and perspectives
por: Edeline, Julien, et al.
Publicado: (2021)

Cognitive assessment in patients treated by immunotherapy: the prospective Cog-Immuno trial
por: Lange, Marie, et al.
Publicado: (2022)

Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy
por: Giannone, Gaia, et al.
Publicado: (2020)

Metformin as an archetype immuno-metabolic adjuvant for cancer immunotherapy
por: Verdura, Sara, et al.
Publicado: (2019)

Immuno-Oncology Biomarkers for Personalized Immunotherapy in Breast Cancer
por: Vafaizadeh, Vida, et al.
Publicado: (2020)

Celebrating a decade of the Journal for ImmunoTherapy of Cancer
por: Romero, Pedro J, et al.
Publicado: (2022)

Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials
por: Kohrt, Holbrook E., et al.
Publicado: (2016)

Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy
por: de Charette, Marie, et al.
Publicado: (2018)

Precision Immuno-Oncology: Prospects of Individualized Immunotherapy for Pancreatic Cancer
por: Zhang, Jiajia, et al.
Publicado: (2018)

Immunotherapies and Combination Strategies for Immuno-Oncology
por: Barbari, Cody, et al.
Publicado: (2020)

French Endocrine Society Guidance on endocrine side effects of immunotherapy
por: Castinetti, F, et al.
Publicado: (2018)

Sequential tumor and dual immune targeted immunotherapy: anti-lymphoma activity of Rituximab with 4-1bb stimulation and PD-1 blockade
por: Mueller, Antonia MS, et al.
Publicado: (2014)

Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC)
por: Atkins, Michael B, et al.
Publicado: (2022)

Have lessons from past failures brought us closer to the success of immunotherapy in metastatic pancreatic cancer?
por: Brunet, Laura Rosa, et al.
Publicado: (2015)

Immuno-reactive cancer organoid model to assess effects of the microbiome on cancer immunotherapy
por: Shelkey, Ethan, et al.
Publicado: (2022)

The Cancer Moonshot Immuno-Oncology Translational Network at 5: accelerating cancer immunotherapies
por: Annapragada, Ananth, et al.
Publicado: (2023)

The Immuno-Modulatory Effects of Inhibitor of Apoptosis Protein Antagonists in Cancer Immunotherapy
por: Michie, Jessica, et al.
Publicado: (2020)

Precision Tools in Immuno-Oncology: Synthetic Gene Circuits for Cancer Immunotherapy
por: Bonfá, Giuliano, et al.
Publicado: (2020)

A microsimulation model to assess the economic impact of immunotherapy in non-small cell lung cancer
por: Legoupil, Clémence, et al.
Publicado: (2020)

High baseline prevalence of atopic comorbidities and medication use in children treated with allergy immunotherapy in the REAl-world effeCtiveness in allergy immunoTherapy (REACT) study
por: Fritszching, Benedikt, et al.
Publicado: (2023)

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19
por: Ascierto, Paolo Antonio, et al.
Publicado: (2020)

FITC labeling of human insulin and transport of FITC-insulin conjugates through MDCK cell monolayer
por: Shah, Darshana, et al.
Publicado: (2019)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma
por: McNeel, Douglas G., et al.
Publicado: (2016)

Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
por: Kamat, Ashish M., et al.
Publicado: (2017)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma
por: Shah, Nina, et al.
Publicado: (2020)

The Society for Immunotherapy of Cancer clinical practice guideline on immunotherapy for hepatocellular carcinoma
por: Kudo, Masatoshi
Publicado: (2023)

DGK-α: A Checkpoint in Cancer-Mediated Immuno-Inhibition and Target for Immunotherapy
por: Noessner, Elfriede
Publicado: (2017)

Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy
por: Pan, Chongxian, et al.
Publicado: (2020)

CRISPR/Cas9 system: recent applications in immuno-oncology and cancer immunotherapy
por: Chen, Chen, et al.
Publicado: (2023)

Correction: Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19
Publicado: (2020)

Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development
por: Tawbi, Hussein A, et al.
Publicado: (2023)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer
por: Emens, Leisha A, et al.
Publicado: (2021)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer
por: Galsky, Matthew D, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8elm3m855phtdrn4q29p3vl5to